In the workers’ compensation ecosystem, certain injuries dominate attention because of their frequency or severity. Yet some of the most financially damaging claims are not the ones that occur most often, they are the ones that quietly linger, get denied, become litigated, and ultimately cost employers far more than anyone anticipates. Carpal Tunnel Syndrome (CTS) is one of those injuries.
While CTS claims may not represent high volume, they consistently represent high friction. They are disproportionately denied, frequently litigated, and notoriously expensive to resolve. In many ways, they are the “hidden legal minefield” of workers’ compensation, an injury that appears simple on the surface but carries a price tag that can easily exceed $34,000 per claim.
Today, however, the landscape is shifting. Innovative clinical models like the one offered by MinWorx Health prove that CTS does not need to be a long, costly, or contentious claim. With minimally invasive treatment, rapid recovery, and a total episode‑of‑care cost what typical conservative treatment costs, MinWorx is demonstrating that the industry can dramatically reduce spend, improve outcomes, and close claims in a fraction of the time.
This is more than a clinical improvement—it is a transformation of claims.
The Denial Problem: Why CTS Claims Become a Legal Quagmire
Across the U.S., studies and industry analyses suggest that approximately 13% to 25% of initial workers’ compensation claims face denial, depending on state and jurisdiction.
But CTS claims face even higher scrutiny because carpal tunnel can be influenced by non‑occupational factors: genetics, age, hobbies, pregnancy, diabetes, insurers often challenge causation. The result is predictable:
• Higher denial rates
• More litigation
• Longer claim duration
• Higher total payouts
In states like California, where litigation is common, even claims that are ultimately accepted often endure months, or years, of dispute before reaching resolution.
This is where the financial impact becomes staggering.
The True Cost of Litigation: A $34,000 Injury That Can Double or Triple in Cost
According to the National Council on Compensation Insurance (NCCI), the average cost of a carpal tunnel claim in 2021–2022 was $34,774. But that number only tells part of the story.
Once litigation enters the picture, costs escalate dramatically:
Litigated vs. Non‑Litigated CTS Claims
• Average claim duration with an attorney: 901 days
• Average claim duration without an attorney: 305 days
• Average total payout with attorney involvement: $77,807
• Average total payout without attorney involvement: $15,936
And then there are the legal fees. Workers’ compensation attorneys typically take 10% to 33% of the settlement. On a $34,000 claim, that means:
• $3,400 to $11,000 in attorney fees
• Plus court costs
• Plus expert medical testimony
• Plus additional diagnostics
• Plus extended indemnity
All for a condition that can be definitively treated in minutes. This is the definition of unnecessary spend.
The Clinical Reality: Traditional Pathways Delay Recovery and Inflate Costs
The conventional CTS treatment pathway is slow, fragmented, and expensive. It often includes:
• EMG/NCS testing
• Multiple physician visits
• Physical therapy
• Steroid injections
• Delayed surgical referral
• Extended time off work
Yet research consistently shows that therapy and injections offer only temporary symptom relief. They do not resolve the underlying compression of the median nerve. If you keep putting a band aid on the symptoms the claim remains open and costs just continue to rise.
In other words, the traditional pathway delays the inevitable and increases the cost of getting there.
The MinWorx Health Solution: A Definitive Fix That Closes Claims Faster
During my search for organizations that exemplify best practices, I discovered MinWorx Health. Their approach to care stands out as a model of integrity and innovation, setting a new standard for what is possible in the industry.
MinWorx Health is redefining how CTS is managed in workers’ compensation by offering a complete episode of care model which includes a minimally invasive procedure:
• Developed by two Mayo Clinic Physicians
• Comparable to a dental procedure
• Performed in minutes
• Allows patients to drive themselves to and from the appointment
• Allows return to normal activities within 14 days
While also providing industry leading guarantees, including:
- Full RTW release within 14 days of procedure
- No revision surgery within 12 months of procedure (industry standard for surgical bundles is 90 days)
The recovery is so rapid that even surgeons who have undergone the procedure report returning to performing complex surgeries within days. The guidelines indicate full duty release typically by post-op Day 14. Also, unlike open or mini-open procedures, the patient can undergo bilateral wrists on the same day with no issues.
This is a stark contrast to traditional open or endoscopic surgery, which often requires weeks, or months, of recovery.
Screening Without EMG/NCS: Eliminating Delays and Unnecessary Costs
One of the most powerful components of the MinWorx Health model is the ability to identify appropriate candidates without EMG/NCS testing. Using validated clinical screening tools, patients can be accurately diagnosed at the point of injury or through occupational health.
This eliminates:
• Costly diagnostics
• Delays in care
• Confusion around causation
• Opportunities for disputes
• Unnecessary treatment steps
When CTS is identified early and routed directly into the MinWorx Health pathway, the claim trajectory changes immediately.
The Financial Impact: Reduce your spend by 66%
The entire MinWorx Health episode of care costs well below the average cost of a CTS claim. That includes:
• Screening
• Procedure
• Follow‑up
• Return‑to‑work release guarantees
When compared to the $34,774 average cost of a CTS claim and the $77,807 average cost of a litigated claim: the savings are undeniable.
The MinWorx Health Advantage
• Eliminates unnecessary diagnostics
• Avoids therapy and injections that don’t resolve the condition
• Reduces indemnity exposure
• Prevents litigation
• Closes claims within six weeks when referred promptly
• Achieves consistently high patient satisfaction rating (9.5/10)
This is not incremental improvement. This is a step‑change in how CTS claims are managed.
A System Ready for Disruption
Some may resist this model because it disrupts entrenched workflows and revenue streams. But the industry is at an inflection point. Employers, TPAs, and carriers are actively seeking solutions that:
• Reduce total cost of risk
• Improve injured worker experience
• Shorten claim duration
• Minimize litigation
• Deliver predictable outcomes
MinWorx Health is doing exactly that.
This is not theoretical. It is happening now. The data, the clinical outcomes, and the patient experiences all point to the same conclusion: this model works.
Your Next Step: Evaluate Your CTS Spend
Look at your data.
Look at your denial rates.
Look at your litigation rates.
Look at your average cost per CTS claim.
Then ask yourself- What would it mean for your organization if you could reduce the expenditure per episode and close the claim within six weeks?
This is your pivotal moment, the chance to break free from the costly cycle of denial, litigation, and delay. The path to transformation is right before you, and with MinWorx Health as your ally, you have the power to redefine what’s possible for your organization and your people.
